DRDOCK: A Drug Repurposing platform integrating automated docking, simulations and a log-odds-based drug ranking scheme
Abstract
MotivationDrug repurposing, where drugs originally approved to treat a disease are reused to treat other diseases, has received escalating attention especially in pandemic years. Structure-based drug design, integrating small molecular docking, molecular dynamic (MD) simulations and AI, has demonstrated its evidenced importance in streamlining new drug development as well as drug repurposing. To perform a sophisticated and fully automated drug screening using all the FDA drugs, intricate programming, accurate drug ranking methods and friendly user interface are very much needed. ResultsHere we introduce a new web server, DRDOCK, Drug Repurposing DOcking with Conformation-sampling and pose re-ranKing - refined by MD and statistical models, which integrates small molecular docking and molecular dynamic (MD) simulations for automatic drug screening of 2016 FDA-approved drugs over a user-submitted single-chained target protein. The drugs are ranked by a novel drug-ranking scheme using log-odds (LOD) scores, derived from feature distributions of true binders and decoys. Users can submit a selection of LOD-ranked poses for further MD-based binding affinity evaluation. We demonstrated that our platform can indeed recover one of the substrates for nsp16, a cap ribose 2'-O methyltransferase, and recommends that fluralaner, tegaserod and fenoterol could be repurposed for the COVID19 treatment with the latter two being confirmed in SARS-CoV2 suppression experiments. All the sampled docking poses and trajectories can be 3D-viewed and played via our web interface. This platform shall be easy-to-use for general scientists and medicinal researchers to carry out drug repurposing within a couple of days which should add value to our timely responses to, particularly, emergent disease outbreaks. Availability and implementationDRDOCK can be freely accessed from https://dyn.life.nthu.edu.tw/drdock/. (Due to the hardware upgrade, the service is NOT available before 7/18, 2021)
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 3
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Multiscale virtual screening optimization for shotgun drug repurposing using the CANDO platform
Matthew L. Hudson, Ram Samudrala·MoleculesPeer-reviewed·Apr 28, 2021
- Exploration of interaction scoring criteria in the CANDO platform
Zackary Falls, William Mangione, … Ram Samudrala·BMC Research NotesPeer-reviewed·Jun 7, 2019
- Identifying protein subsets and features responsible for improved drug repurposing accuracies using the CANDO platform
William Mangione, Ram Samudrala·MoleculesPeer-reviewed·Jan 4, 2019
- A deep learning-based drug repurposing screening and validation for anti-SARS-CoV-2 compounds by targeting the cell entry mechanism
- An Agentic Platform for Drug Repurposing Unified across Molecular, Phenotypic, and Clinical Scales
C Wang, Mohamed El Moussaoui, … Kuan‐lin Huang·bioRxiv·Jun 7, 2026
- EK-DRD: a comprehensive database for drug repositioning inspired by experimental knowledge
Chongze Zhao, Xi Dai, … Ling Wang·Journal of Chemical Information and ModelingPeer-reviewed·Aug 21, 2019